Investing.com -- Jefferies in a note dated Wednesday has initiated coverage on Hansa Biopharma AB with a “buy” rating and a price target of SEK 100, citing momentum from its first-in-class ...
Q3 2025 Earnings Call Transcript October 28, 2025 GeneDx Holdings Corp. misses on earnings expectations. Reported EPS is ...
Boeing reported earnings on Wednesday. The FAA recently lifted its monthly production cap. The Dow Jones manufacturer still ...